Cnb Bank Viatris Inc Transaction History

Cnb Bank

$215 Million
Q3 2024

A detailed history of Cnb Bank transactions in Viatris Inc stock. As of the latest transaction made, Cnb Bank holds 3,126 shares of VTRS stock, worth $40,638. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,126

Previous 3,126 -0.0%

Holding current value

$40,638

Previous $33,000 9.09%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$10.05 - $12.02 $1,467 - $1,754	-146 Reduced 4.46%	3,126 $33,000
Q1 2024 May 02, 2024	SELL	$11.27 - $13.53 $1,656 - $1,988	-147 Reduced 4.3%	3,272 $39,000
Q3 2023 Nov 02, 2023	BUY	$9.59 - $11.35 $546 - $646	57 Added 1.7%	3,419 $33,000
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $950 - $1,260	109 Added 3.35%	3,362 $37,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $1,043 - $1,368	-123 Reduced 3.64%	3,253 $28,000
Q2 2022 Aug 19, 2022	SELL	$9.95 - $12.27 $14,696 - $18,122	-1,477 Reduced 30.43%	3,376 $35,000
Q2 2022 Aug 10, 2022	BUY	$9.95 - $12.27 $14,696 - $18,122	1,477 Added 43.75%	4,853 $50,000
Q1 2022 Apr 13, 2022	BUY	$9.81 - $15.4 $2,589 - $4,065	264 Added 8.48%	3,376 $37,000
Q4 2021 Jan 31, 2022	SELL	$12.09 - $14.68 $1,354 - $1,644	-112 Reduced 3.47%	3,112 $42,000
Q3 2021 Nov 02, 2021	BUY	$13.25 - $15.13 $1,258 - $1,437	95 Added 3.04%	3,224 $44,000
Q2 2021 Jul 29, 2021	BUY	$12.97 - $16.15 $1,050 - $1,308	81 Added 2.66%	3,129 $45,000
Q1 2021 May 03, 2021	SELL	$13.59 - $18.54 $37,657 - $51,374	-2,771 Reduced 47.62%	3,048 $42,000
Q4 2020 Jan 27, 2021	BUY	$14.3 - $18.74 $83,211 - $109,048	5,819 New	5,819 $109,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

934M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cnb Bank with notifications on news.

Account